PH20237A - Liquid prolonged releage pharmaceutical formulation containing ionic constituents - Google Patents
Liquid prolonged releage pharmaceutical formulation containing ionic constituentsInfo
- Publication number
- PH20237A PH20237A PH30760A PH30760A PH20237A PH 20237 A PH20237 A PH 20237A PH 30760 A PH30760 A PH 30760A PH 30760 A PH30760 A PH 30760A PH 20237 A PH20237 A PH 20237A
- Authority
- PH
- Philippines
- Prior art keywords
- releage
- pharmaceutical formulation
- formulation containing
- containing ionic
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53286483A | 1983-09-16 | 1983-09-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH20237A true PH20237A (en) | 1986-11-10 |
Family
ID=24123487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH30760A PH20237A (en) | 1983-09-16 | 1984-06-04 | Liquid prolonged releage pharmaceutical formulation containing ionic constituents |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0139881B1 (da) |
JP (1) | JPH0688901B2 (da) |
KR (1) | KR910003557B1 (da) |
AT (1) | ATE42894T1 (da) |
AU (1) | AU565487B2 (da) |
CA (1) | CA1221632A (da) |
DE (1) | DE3478085D1 (da) |
DK (1) | DK164019C (da) |
FI (1) | FI843609L (da) |
IE (1) | IE57445B1 (da) |
IL (1) | IL71886A (da) |
MX (1) | MX171030B (da) |
NO (1) | NO843673L (da) |
NZ (1) | NZ208155A (da) |
PH (1) | PH20237A (da) |
ZA (1) | ZA844023B (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4692462A (en) * | 1985-03-18 | 1987-09-08 | Menley & James Laboratories, Ltd. | Compositions and method of controlling transdermal penetration of topical and systemic agents |
CA1331563C (en) * | 1987-08-03 | 1994-08-23 | Gaylen M. Zentner | Device for the controlled release of drugs with donnan-like modulation by charged insoluble resins |
US4853229A (en) * | 1987-10-26 | 1989-08-01 | Alza Corporation | Method for adminstering tiny pills |
US5186930A (en) * | 1988-11-14 | 1993-02-16 | Schering Corporation | Sustained release oral suspensions |
US4999189A (en) * | 1988-11-14 | 1991-03-12 | Schering Corporation | Sustained release oral suspensions |
SE9103110D0 (sv) | 1991-10-24 | 1991-10-24 | Kabi Pharmacia Ab | New drug formulation |
GB2360894B (en) * | 2000-03-30 | 2004-11-10 | Peter Thomas Bosson | Display device support system |
CA2689101C (en) * | 2007-05-30 | 2013-01-22 | Neos Therapeutics, Lp | Modifying drug release in suspensions of ionic resin systems |
EP2836201A1 (en) | 2011-12-14 | 2015-02-18 | Wockhardt Limited | Modified release liquid pharmaceutical composition comprising bromopheniramine, pseudoephedrine and dextromethorphan |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2990332A (en) * | 1958-04-02 | 1961-06-27 | Wallace & Tiernan Inc | Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith |
US3138525A (en) * | 1961-06-16 | 1964-06-23 | Hoffmann La Roche | Castor wax-amprotropine-resin compositions |
FR5227M (da) * | 1966-03-18 | 1967-08-14 | ||
DE2246037B2 (de) * | 1972-09-20 | 1975-02-27 | Taeschner & Co, 8831 Kipfenberg | Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform |
US4221778A (en) * | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
-
1984
- 1984-05-10 AU AU27891/84A patent/AU565487B2/en not_active Expired
- 1984-05-14 NZ NZ208155A patent/NZ208155A/en unknown
- 1984-05-15 IE IE1201/84A patent/IE57445B1/en not_active IP Right Cessation
- 1984-05-17 CA CA000454575A patent/CA1221632A/en not_active Expired
- 1984-05-21 IL IL71886A patent/IL71886A/xx not_active IP Right Cessation
- 1984-05-28 ZA ZA844023A patent/ZA844023B/xx unknown
- 1984-06-04 PH PH30760A patent/PH20237A/en unknown
- 1984-07-10 JP JP59141550A patent/JPH0688901B2/ja not_active Expired - Lifetime
- 1984-07-20 EP EP84108609A patent/EP0139881B1/en not_active Expired
- 1984-07-20 DE DE8484108609T patent/DE3478085D1/de not_active Expired
- 1984-07-20 AT AT84108609T patent/ATE42894T1/de not_active IP Right Cessation
- 1984-09-11 MX MX008246A patent/MX171030B/es unknown
- 1984-09-12 DK DK434784A patent/DK164019C/da not_active IP Right Cessation
- 1984-09-14 NO NO843673A patent/NO843673L/no unknown
- 1984-09-14 FI FI843609A patent/FI843609L/fi not_active Application Discontinuation
- 1984-09-15 KR KR1019840005637A patent/KR910003557B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR910003557B1 (ko) | 1991-06-05 |
EP0139881A1 (en) | 1985-05-08 |
KR850002399A (ko) | 1985-05-13 |
EP0139881B1 (en) | 1989-05-10 |
FI843609L (fi) | 1985-03-17 |
IE841201L (en) | 1985-03-16 |
AU565487B2 (en) | 1987-09-17 |
ZA844023B (en) | 1985-03-27 |
IE57445B1 (en) | 1992-09-09 |
MX171030B (es) | 1993-09-27 |
CA1221632A (en) | 1987-05-12 |
DK434784A (da) | 1985-03-17 |
DE3478085D1 (en) | 1989-06-15 |
FI843609A0 (fi) | 1984-09-14 |
DK164019B (da) | 1992-05-04 |
IL71886A (en) | 1987-11-30 |
JPH0688901B2 (ja) | 1994-11-09 |
NZ208155A (en) | 1987-09-30 |
AU2789184A (en) | 1985-03-21 |
DK164019C (da) | 1992-09-28 |
NO843673L (no) | 1985-03-18 |
JPS6067418A (ja) | 1985-04-17 |
ATE42894T1 (de) | 1989-05-15 |
IL71886A0 (en) | 1984-09-30 |
DK434784D0 (da) | 1984-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY101544A (en) | Pharmaceutical composition for external use containing active-type vitamin d3. | |
AU589678B2 (en) | Gelatine capsules and process for their manufacture | |
DE3173434D1 (en) | Trisubstituted imidazole derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use | |
AU4936890A (en) | Medicament containing dihydrolipoic acid as active substance | |
NZ198106A (en) | Pharmaceutical powder containing microencapsulated bacampicillin acid addition salt | |
AU6619686A (en) | Time duration indicator systems, and also products containing such indicator systems having a limited duration of use or life | |
IL84598A0 (en) | Pharmaceutical agents containing metal complexes | |
EP0282000A3 (en) | Cationically electrodepositable finely divided gelled polymer and cationically electrodepositable coating composition containing same | |
AU514408B2 (en) | Delivery means for biological active agents | |
GR3001185T3 (en) | Stable solid pharmaceutical composition containing ibuprofen and codeine | |
PH20237A (en) | Liquid prolonged releage pharmaceutical formulation containing ionic constituents | |
AU517568B2 (en) | Polyamide carrier for fixing biologically active proteins | |
AU6913581A (en) | Implantable blood access tee | |
AU562216B2 (en) | Coated pharmaceutical preparations | |
IE883445L (en) | Stable aqueous solutions of antibodies | |
SE8300320L (sv) | Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning | |
AU6821687A (en) | System for delivering drug with enhanced bioacceptability | |
DE3671034D1 (de) | Pulverfoermige beschichtungszusammensetzung. | |
NO880179D0 (no) | Polymerkomplekser, fremgangsmaate for fremstilling av disse, og farmasoeytiske midler inneholdende disse. | |
JPS56154417A (en) | Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it | |
AU540778B2 (en) | Coated formulation | |
AU4734993A (en) | Nutrient or medicinal compositions for administration to ruminants | |
AU1246783A (en) | Non-contact dosing syringe | |
DK307085A (da) | 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
DE2962429D1 (en) | A pharmaceutical composition comprising an amino acid for reducing blood serum prolactin levels |